| rAAV6-microdystrophin preserves muscle function and extends lifespan in severely dystrophic mice P Gregorevic, JM Allen, E Minami, MJ Blankinship, M Haraguchi, L Meuse, ... Nature medicine 12 (7), 787-789, 2006 | 363 | 2006 |
| Design of tissue-specific regulatory cassettes for high-level rAAV-mediated expression in skeletal and cardiac muscle MZ Salva, CL Himeda, PWL Tai, E Nishiuchi, P Gregorevic, JM Allen, ... Molecular Therapy 15 (2), 320-329, 2007 | 254 | 2007 |
| Modifying the insect cell N-glycosylation pathway with immediate early baculovirus expression vectors DL Jarvis, EE Finn Nature biotechnology 14 (10), 1288-1292, 1996 | 205 | 1996 |
| Biochemical analysis of the N-glycosylation pathway in baculovirus-infected lepidopteran insect cells DL Jarvis, EE Finn Virology 212 (2), 500-511, 1995 | 203 | 1995 |
| Microutrophin delivery through rAAV6 increases lifespan and improves muscle function in dystrophic dystrophin/utrophin-deficient mice GL Odom, P Gregorevic, JM Allen, E Finn, JS Chamberlain Molecular Therapy 16 (9), 1539-1545, 2008 | 139 | 2008 |
| Successful regional delivery and long-term expression of a dystrophin gene in canine muscular dystrophy: a preclinical model for human therapies Z Wang, R Storb, CL Halbert, GB Banks, TM Butts, EE Finn, JM Allen, ... Molecular Therapy 20 (8), 1501-1507, 2012 | 90 | 2012 |
| Functional capacity of dystrophins carrying deletions in the N-terminal actin-binding domain GB Banks, P Gregorevic, JM Allen, EE Finn, JS Chamberlain Human molecular genetics 16 (17), 2105-2113, 2007 | 72 | 2007 |
| Evaluation of vascular delivery methodologies to enhance rAAV6-mediated gene transfer to canine striated musculature P Gregorevic, BR Schultz, JM Allen, JB Halldorson, MJ Blankinship, ... Molecular Therapy 17 (8), 1427-1433, 2009 | 43 | 2009 |
| Heparin-binding correlates with increased efficiency of AAV1-and AAV6-mediated transduction of striated muscle, but negatively impacts CNS transduction ALH Arnett, LR Beutler, A Quintana, J Allen, E Finn, RD Palmiter, ... Gene therapy 20 (5), 497-503, 2013 | 39 | 2013 |
| Evidence for early local viral replication and local production of antiviral immunity upon mucosal simian-human immunodeficiency virus SHIV89. 6 infection in Macaca nemestrina Z Ambrose, K Larsen, J Thompson, Y Stevens, E Finn, SL Hu, ML Bosch Journal of virology 75 (18), 8589-8596, 2001 | 27 | 2001 |
| Biodistribution and safety profile of recombinant adeno-associated virus serotype 6 vectors following intravenous delivery D Stone, Y Liu, ZY Li, R Strauss, EE Finn, JM Allen, JS Chamberlain, ... Journal of virology 82 (15), 7711-7715, 2008 | 25 | 2008 |
| Engineered DNA plasmid reduces immunity to dystrophin while improving muscle force in a model of gene therapy of Duchenne dystrophy PP Ho, LJ Lahey, F Mourkioti, PE Kraft, A Filareto, M Brandt, ... Proceedings of the National Academy of Sciences 115 (39), E9182-E9191, 2018 | 22 | 2018 |
| Characterization of a maternal–fetal HIV transmission model using pregnant macaques infected with HIV‐2287 RJY Ho, K Larsen, L Kinman, C Sherbert, XY Wang, E Finn, C Nosbisch, ... Journal of medical primatology 30 (3), 131-140, 2001 | 13 | 2001 |
| Suppression of maternal virus load with zidovudine, didanosine, and indinavir combination therapy prevents mother-to-fetus HIV transmission in macaques RJY Ho, K Larsen, T Bui, XY Wang, AM Herz, C Sherbert, E Finn, ... JAIDS Journal of Acquired Immune Deficiency Syndromes 25 (2), 140-149, 2000 | 11 | 2000 |
| Systemic delivery of rAAV6-microdystrophin preserves muscle function and extends lifespan in a murine model of severe muscular dystrophy P Gregorevic, JM Allen, E Minami, MJ Blankinship, M Haraguchi, L Meuse, ... Nature medicine 12 (7), 787, 2006 | 4 | 2006 |
| Evaluation of the immunogenicity and efficacy of an rVSV vaccine against Zika virus infection in macaca nemestrina J Tisoncik-Go, KM Voss, TB Lewis, AE Muruato, LR Kuller, EE Finn, ... Frontiers in Virology 3, 1108420, 2023 | 3 | 2023 |
| Extracorporeal delivery of rAAV with metabolic exchange and oxygenation S Bieber, JB Halldorson, E Finn, S Ahmad, JS Chamberlain, GL Odom Scientific Reports 3 (1), 1538, 2013 | 2 | 2013 |
| 513. Novel Characteristics of Heparin Binding by Adeno-Associated Virus Serotype 6 JM Allen, EE Finn, JS Chamberlain Molecular Therapy, 199, 2005 | 2 | 2005 |
| FP42-TH-02 Development of gene therapy for Duchenne muscular dystrophy using systemic delivery of AAV vectors JS Chamberlain, P Gregorevic, B Schultz, G Odom, E Finn Journal of the Neurological Sciences, S124, 2009 | 1 | 2009 |
| Suppression of maternal virus load with AZT, DDI, and indinavir combination therapy prevents mother-to-fetus HIV transmission in macaques HO RJY, K Larsen, T Bui, XY Wang, AM HERZ, C Sherbert, E Finn, ... J Acquir Immune Defic Syndr 25, 140-149, 2000 | 1 | 2000 |
